Your browser doesn't support javascript.
loading
Clinical impact of STK11 mutation in advanced-stage non-small cell lung cancer.
Rosellini, Pietro; Amintas, Samuel; Caumont, Charline; Veillon, Rémi; Galland-Girodet, Sigolène; Cuguillière, Alain; Nguyen, Laurent; Domblides, Charlotte; Gouverneur, Amandine; Merlio, Jean-Philippe; Bezin, Julien; Girodet, Pierre-Olivier.
Afiliação
  • Rosellini P; CHU de Bordeaux, CIC1401, Service de Pharmacologie Médicale, Service de Biologie des tumeurs, Service des Maladies Respiratoires, F-33000 Pessac, France.
  • Amintas S; CHU de Bordeaux, CIC1401, Service de Pharmacologie Médicale, Service de Biologie des tumeurs, Service des Maladies Respiratoires, F-33000 Pessac, France; Univ. Bordeaux, Inserm CIC1401, Inserm CR1219, Inserm U1035, F-33000 Bordeaux, France.
  • Caumont C; CHU de Bordeaux, CIC1401, Service de Pharmacologie Médicale, Service de Biologie des tumeurs, Service des Maladies Respiratoires, F-33000 Pessac, France.
  • Veillon R; CHU de Bordeaux, CIC1401, Service de Pharmacologie Médicale, Service de Biologie des tumeurs, Service des Maladies Respiratoires, F-33000 Pessac, France.
  • Galland-Girodet S; Polyclinique Bordeaux Nord Aquitaine, F-33000 Bordeaux, France.
  • Cuguillière A; Bagatelle Hôpital d'instruction des Armées, F-33000 Villenave-d'Ornon, France.
  • Nguyen L; Clinique Saint Augustin, F-33000 Bordeaux, France.
  • Domblides C; Department of Medical Oncology, Hôpital Saint-André, CHU Bordeaux-University of Bordeaux, F-33000 Bordeaux, France; ImmunoConcEpt, CNRS UMR 5164, Bordeaux University, F-33000 Bordeaux, France.
  • Gouverneur A; CHU de Bordeaux, CIC1401, Service de Pharmacologie Médicale, Service de Biologie des tumeurs, Service des Maladies Respiratoires, F-33000 Pessac, France; Univ. Bordeaux, Inserm CIC1401, Inserm CR1219, Inserm U1035, F-33000 Bordeaux, France.
  • Merlio JP; CHU de Bordeaux, CIC1401, Service de Pharmacologie Médicale, Service de Biologie des tumeurs, Service des Maladies Respiratoires, F-33000 Pessac, France; Univ. Bordeaux, Inserm CIC1401, Inserm CR1219, Inserm U1035, F-33000 Bordeaux, France.
  • Bezin J; CHU de Bordeaux, CIC1401, Service de Pharmacologie Médicale, Service de Biologie des tumeurs, Service des Maladies Respiratoires, F-33000 Pessac, France; Univ. Bordeaux, Inserm CIC1401, Inserm CR1219, Inserm U1035, F-33000 Bordeaux, France.
  • Girodet PO; CHU de Bordeaux, CIC1401, Service de Pharmacologie Médicale, Service de Biologie des tumeurs, Service des Maladies Respiratoires, F-33000 Pessac, France; Univ. Bordeaux, Inserm CIC1401, Inserm CR1219, Inserm U1035, F-33000 Bordeaux, France. Electronic address: pierre-olivier.girodet@u-bordeaux.fr.
Eur J Cancer ; 172: 85-95, 2022 Sep.
Article em En | MEDLINE | ID: mdl-35759814
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies Limite: Humans Idioma: En Revista: Eur J Cancer Ano de publicação: 2022 Tipo de documento: Article País de afiliação: França
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies Limite: Humans Idioma: En Revista: Eur J Cancer Ano de publicação: 2022 Tipo de documento: Article País de afiliação: França